The finding suggests that C4.4A glycosylation differs between tumour cell lines and the immortalized keratinocyte line HaCaT, such that binding sites for anti-hC4.4A-N and probably anti-hC4.4A-C are frequently masked by sugar chains in tumour lines. Here, C4A is linked to neoplasm.